Open AccessCost–Utility Analysis of a Latanoprost Cationic Emulsion (STN1013001) versus Other Latanoprost in the Treatment of Open-Angle Glaucoma or Ocular Hypertension and Concomitant Ocular Surface Disease in Germany
Author(s) -
Carlo Lazzaro,
Cécile van Steen,
Stephan Billeit,
Heinrich Frauenknecht,
Ulrich Thelen,
Stefan Pfennigsdorf,
Ulrich Thelen,
Luigi Angelillo
Publication year - 2022
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s351013
Subject(s) - latanoprost , medicine , ocular hypertension , glaucoma , ophthalmology , concomitant , open angle glaucoma , optometry , surgery
This study aimed to estimate the cost-utility and economic value of STN1013001, a latanoprost cationic emulsion vs other latanoprost formulations (henceforth latanoprost) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT) and concomitant ocular surface disease (OSD) in Germany.